Defining a testing approach has to account for many factors, a lot of which are not within control. It is therefore extremely important that the testing decided upon should be aligned with the ...
Clinical value of timely targeted therapy (TT) for patients with advanced non-small cell lung cancer (aNSCLC) with actionable driver oncogenes (ADO).